Page last updated: 2024-08-24

peptide t and peptide t amide

peptide t has been researched along with peptide t amide in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19903 (21.43)18.7374
1990's5 (35.71)18.2507
2000's3 (21.43)29.6817
2010's3 (21.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dzierzanowska-Madalińska, D; Imielska, D; Kupryszewski, G; Maćkiewicz, Z; Madaliński, K; Walczak, M1
Burke, TR; Knight, M; Mack, GD; Perkins, R1
Banks, WA; Barrera, CM; Kastin, AJ1
Burke, TR; Knight, M1
Amidon, GL; Su, SF1
Anderson, WB; Evain-Brion, D; Liapi, C; Raynaud, F; Takahashi, N1
Farber, EM; Raychaudhuri, SK; Raychaudhuri, SP1
Brenneman, DE; Hauser, J; Pert, CB; Phillips, TM; Ruff, M; Spong, CY1
Leoung, GS; Pert, CB; Polianova, M; Ruff, MR; Ruscetti, FW; Yang, QE1
Pert, CB; Polianova, MT; Ruff, MR; Ruscetti, FW1
Asthana, D; Atkinson, JH; Goodkin, K; Heseltine, PN; Khamis, I; Lyman, WD; Molina, R; Shapshak, P; Vitiello, B; Wilkie, FL; Zheng, W1
Fukazawa, Y; Kiguchi, N; Kishioka, S; Kobayashi, Y; Saika, F1
Baamonde, A; Hidalgo, A; Lastra, A; Meana, Á; Menéndez, L; Pevida, M1
Chen, J; Li, H; Li, L; Liu, K; Shen, Y; Zhi, D1

Reviews

1 review(s) available for peptide t and peptide t amide

ArticleYear
Update on D-ala-peptide T-amide (DAPTA): a viral entry inhibitor that blocks CCR5 chemokine receptors.
    Current HIV research, 2003, Volume: 1, Issue:1

    Topics: CCR5 Receptor Antagonists; Clinical Trials, Phase II as Topic; HIV Infections; HIV-1; Humans; Peptide T; Receptors, HIV; Virus Replication

2003

Trials

2 trial(s) available for peptide t and peptide t amide

ArticleYear
Anti-chemotactic activities of peptide-T: a possible mechanism of actions for its therapeutic effects on psoriasis.
    International journal of immunopharmacology, 1998, Volume: 20, Issue:11

    Topics: Adult; Chemokine CCL5; Chemotaxis, Leukocyte; Female; Humans; Male; Middle Aged; Monocytes; Peptide T; Psoriasis; T-Lymphocytes

1998
Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment.
    Journal of neurovirology, 2006, Volume: 12, Issue:3

    Topics: Adolescent; Adult; AIDS Dementia Complex; Cerebrospinal Fluid; Female; HIV-1; Humans; Leukocyte Count; Male; Monocytes; Peptide T; Plasma; Reproducibility of Results; Serum; Treatment Outcome; Viral Load

2006

Other Studies

11 other study(ies) available for peptide t and peptide t amide

ArticleYear
The influence of D-Ala1-peptide T amide, an analogue of HIV glycoprotein 120 fragment, on the CD4--anti CD4 lymphocyte interaction.
    Archivum immunologiae et therapiae experimentalis, 1991, Volume: 39, Issue:1-2

    Topics: Amino Acid Sequence; Antigen-Antibody Reactions; Binding Sites; Binding, Competitive; HIV Envelope Protein gp120; Humans; In Vitro Techniques; Lymphocytes; Molecular Sequence Data; Peptide T; Receptors, HIV

1991
Reversed-phase preparative chromatography of [D-Ala1]-peptide T amide.
    Journal of chromatography, 1988, Jul-01, Volume: 444

    Topics: Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Oligopeptides; Peptide T

1988
D-[Ala1]-peptide T-amide is transported from blood to brain by a saturable system.
    Brain research bulletin, 1987, Volume: 19, Issue:6

    Topics: Animals; Blood-Brain Barrier; Chromatography, High Pressure Liquid; Iodine Radioisotopes; Kinetics; Male; Mice; Mice, Inbred ICR; Oligopeptides; Peptide T; Technetium Tc 99m Aggregated Albumin

1987
Counter-current chromatographic purification of [D-Ala]peptide T amide.
    Journal of chromatography, 1987, Dec-18, Volume: 411

    Topics: Chromatography, High Pressure Liquid; Countercurrent Distribution; Oligopeptides; Peptide T

1987
Investigation into the intestinal metabolism of [D-Ala1] peptide T amide: implication for oral drug delivery.
    Biochimica et biophysica acta, 1995, Aug-17, Volume: 1245, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amino Acid Sequence; Animals; Hydrogen-Ion Concentration; Intestinal Absorption; Intestine, Small; Male; Microvilli; Molecular Sequence Data; Peptide Fragments; Peptide T; Perfusion; Protease Inhibitors; Rabbits; Rats; Rats, Sprague-Dawley

1995
Effects of [D-Ala1] peptide T-NH2 and HIV envelope glycoprotein gp120 on cyclic AMP dependent protein kinases in normal and psoriatic human fibroblasts.
    The Journal of investigative dermatology, 1998, Volume: 110, Issue:4

    Topics: Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Fibroblasts; HIV Envelope Protein gp120; Humans; Peptide T; Psoriasis; Reference Values; Skin

1998
VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death.
    Brain research, 1999, Aug-14, Volume: 838, Issue:1-2

    Topics: Animals; Cell Death; Cells, Cultured; Chemokine CCL5; Chemokines; Genetic Variation; HIV; HIV Envelope Protein gp120; Neurons; Neurotoxins; Peptide T; Rats; Vasoactive Intestinal Peptide

1999
Chemokine receptor-5 (CCR5) is a receptor for the HIV entry inhibitor peptide T (DAPTA).
    Antiviral research, 2005, Volume: 67, Issue:2

    Topics: CCR5 Receptor Antagonists; Cell Line; HIV Infections; HIV-1; Humans; Peptide T; Receptors, CCR5; Virus Replication

2005
CC-chemokine ligand 4/macrophage inflammatory protein-1β participates in the induction of neuropathic pain after peripheral nerve injury.
    European journal of pain (London, England), 2012, Volume: 16, Issue:9

    Topics: Animals; CCR5 Receptor Antagonists; Chemokine CCL4; Hyperalgesia; Macrophages; Male; Mice; Mice, Inbred ICR; Neuralgia; Peptide T; Peripheral Nerve Injuries; Receptors, CCR5; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schwann Cells; Sciatic Nerve; Sciatic Neuropathy; Up-Regulation

2012
The chemokine CCL5 induces CCR1-mediated hyperalgesia in mice inoculated with NCTC 2472 tumoral cells.
    Neuroscience, 2014, Feb-14, Volume: 259

    Topics: Analysis of Variance; Animals; Bone Neoplasms; Cell Line, Tumor; Chemokine CCL5; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Gene Expression Regulation, Neoplastic; Hyperalgesia; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Transplantation; Pain Measurement; Pain Threshold; Peptide T; Receptors, CCR1; Xanthenes

2014
Effects of CC-chemokine receptor 5 on ROCK2 and P-MLC2 expression after focal cerebral ischaemia-reperfusion injury in rats.
    Brain injury, 2016, Volume: 30, Issue:4

    Topics: Analysis of Variance; Animals; Brain Infarction; Cardiac Myosins; Disease Models, Animal; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; Myosin Light Chains; Neurologic Examination; Peptide T; Rats; Rats, Sprague-Dawley; Receptors, CCR5; Reperfusion Injury; rho-Associated Kinases; Serine

2016